What is the recommendation for ARV treatment in HIV-positive pregnant women during labor?

AIIMS CRE 2025

Obstetrics and Midwifery Nursing

Easy

Appeared in: AIIMS CRE 2025

Explanation

Starting ART promptly during labor is a critical intervention to prevent mother-to-child transmission (MTCT) of HIV.
The primary goal is to rapidly decrease the mother's viral load, minimizing the infant's exposure to the virus during passage through the birth canal.
For women not on ART or with an unknown/high viral load, intrapartum intravenous Zidovudine (AZT) is a standard component of care to provide prophylaxis to the infant.
This immediate action has been shown to reduce the rate of perinatal HIV transmission to less than 1-2%.

Option A: Stopping ART at delivery is contraindicated. It would cause a rebound in the maternal viral load, significantly increasing the risk of transmitting HIV to the newborn during delivery and the immediate postpartum period.
Option B: The onset and duration of labor are unpredictable, making a fixed 12-hour window impractical and risky. The principle is to act immediately upon presentation in labor, as any delay increases the risk of transmission.
Option D: This strategy is ineffective because it completely misses the intrapartum period, which is when the highest risk of transmission occurs due to the infant's exposure to maternal blood and cervicovaginal fluids.

Visual 1: Flowchart: Illustrating the PMTCT protocol for a pregnant woman presenting in labor with unknown HIV status versus a known positive status.
Visual 2: Infographic: Showing the three periods of MTCT (in-utero, intrapartum, postpartum) and the corresponding percentage risk, highlighting why intrapartum intervention is vital.

Clinical Relevance

Nursing practice connection: Knowing Prevention of Mother-to-Child Transmission (PMTCT) of HIV helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Nurses play a vital role in the rapid initiation of intrapartum ART, ensuring correct dosage and continuous infusion of medications like IV Zidovudine.
Patient education and emotional support are crucial, as a new diagnosis or the stress of labor can be overwhelming for the mother. The nurse must provide clear, non-judgmental information.
What if the woman has a consistently suppressed viral load (e.g., less than 50 copies/mL) from being on ART throughout pregnancy? In this case, intravenous ART during labor may not be necessary, and she would continue her oral regimen. The decision depends on her viral load near delivery.

How to Approach the Question

First, identify the core clinical goal of the question: preventing mother-to-child transmission (MTCT) of HIV.
Recall that HIV transmission risk is directly related to the maternal viral load, and the infant's exposure to maternal blood and fluids is highest during labor and delivery.
Analyze the timing of the intervention in each option. To be effective, the intervention must lower the viral load before and during the infant's passage through the birth canal.
Evaluate the options based on urgency and practicality. The intervention must be both immediate and feasible in a clinical setting.
Eliminate options that are too late (after birth), too early/impractical (a fixed time before delivery), or counterproductive (stopping ART). This process will lead to the most logical and effective option.

Concept Tested & Keywords

Concept Tested: Prevention of Mother-to-Child Transmission (PMTCT) of HIV
Stem keywords: ARV treatment, HIV-positive, pregnant women, labor
Lead-in keywords: recommendation
Clinical cues: Age/sex group narrows the expected diagnosis, intervention, or normal reference range.
Negative lead-in flag: false

QCmbrl66DskmlxaBrK88wa